Yarbrough Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Hold |
5,054
| – | – | 0.02% | 125 |
|
|
2025
Q1 | $589K | Hold |
5,054
| – | – | 0.03% | 125 |
|
|
2024
Q4 | $428K | Hold |
5,054
| – | – | 0.02% | 137 |
|
|
2024
Q3 | $454K | Hold |
5,054
| – | – | 0.02% | 142 |
|
|
2024
Q2 | $407K | Hold |
5,054
| – | – | 0.02% | 145 |
|
|
2024
Q1 | $403K | Buy |
+5,054
| New | +$403K | 0.02% | 152 |
|